15May2015 More than Moderna: Who’s Who in mRNA Therapeutics? /Luke Timmerman/2/All, Drugs, Science15 May 2015 Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.